This presentation provides a detailed update on the classification, diagnosis, and pathological pitfalls associated with vascular tumors, particularly focusing on malignant and intermediate-grade lesions in dermatopathology. The speaker outlines the basic categorization of vascular tumors into benign (Hemangiomas, Malformations), malignant (Angiosarcoma), and intermediate (Hemangioendotheliomas, HEs), emphasizing that HEs are distinct entities rather than subtypes. Key updates include the potential reclassification of Kaposi Sarcoma as an intermediate lesion, the utility of C-MYC amplification via FISH for diagnosing radiation-associated Angiosarcoma (a tumor with an 80% mortality rate), and the need to distinguish Angiosarcoma from the much more benign Atypical Vascular Lesion (AVL). The lecture also covers complex intermediate lesions such as Epithelioid HE (often mimicking carcinoma), Kaposiform HE (associated with Kasabach-Merritt syndrome), and Epithelioid Sarcoma-Like HE, highlighting the crucial role of clinical history and specialized immunostains (like INI1 and vascular markers) in achieving an accurate diagnosis and prognostication.
Vascular Tumors: Classification, Updates, and Pitfalls in Dermatopathology
0:00 – 1:12 Classification Overview: Vascular tumors are categorized into:
Benign: Hemangiomas (endothelial cell proliferations) and Vascular Malformations (congenital abnormalities).
Malignant: Kaposi Sarcoma (KS) and Angiosarcoma (AS).
Intermediate Potential: The Hemangioendothelioma (HE) group (e.g., Kaposiform, Epithelioid). These entities are distinct and unrelated, sharing only the "HE" name.
2:53 – 3:18 Reclassification of KS: The speaker supports reclassifying Kaposi Sarcoma as an intermediate-behavior lesion, as patients rarely die from it, in stark contrast to Angiosarcoma, which has an 80% mortality rate.
3:44 – 5:26 Diagnostic Difficulty: Diagnosis is challenging due to the numerous subtypes, variable nomenclature in literature, clinical similarity (often just a red/purple lesion), and microscopic overlap (benign lesions mimicking malignancy, and vice versa).
5:55 – 7:45 Angiosarcoma (AS) Clinical Settings: AS commonly occurs on the head/neck of sun-damaged elderly patients or arises iatrogenically following radiation therapy (especially breast cancer treatment) or in chronic lymphedema. It is very rare in young patients/children.
8:38 – 12:40 AS Histological Clues: Classic AS shows infiltrating, ramifying vascular channels dissecting dermal collagen bundles, lined by markedly atypical, hyperchromatic endothelial cells that tend to multi-layer (a key malignancy feature). AS can also present with solid, pleomorphic areas, mimicking undifferentiated sarcoma.
13:40 – 15:06 C-MYC Amplification Update: C-MYC amplification (detectable via FISH) is found in post-radiation and post-lymphedema AS, but usually not in sun-damaged AS. This is a highly sensitive and specific diagnostic tool to confirm AS in difficult post-radiation cases.
15:08 – 17:42 Grave Prognosis: AS has a terrible prognosis; most patients die within 12 months. Treatment includes aggressive surgery, often supplemented by chemo/radiation. Recurrence is common due to early access to the vasculature. The video displays disturbing images illustrating the aggressive nature of advanced AS.
18:27 – 20:37 Clinical Pitfalls in AS: AS can resemble solar purpura or a simple bruise. Clinicians must repeat biopsies if clinical suspicion for AS remains high despite an initially negative small biopsy. Dermatologists should actively screen radiation sites and lymphedema areas for changes.
Clinical Distinction: AVL appears as small, flesh-colored papules (key differentiator from AS, which presents as large plaques or nodules).
Histological Distinction: AVL is infiltrative but generally lacks atypia, mitoses, or multi-layering.
Molecular Distinction: AVL is negative for C-MYC amplification (unlike post-radiation AS).
27:43 – 29:21 Hemangioendotheliomas (HEs) Status: HEs have "intermediate malignant potential" (local/regional spread common; distant mets/death uncommon, excluding EHE). The term "Hemangioendothelioma Not Otherwise Specified" should be avoided to prevent the category from becoming a "waste basket" diagnosis.
29:43 – 33:49 Epithelioid Hemangioendothelioma (EHE): Associated with high mortality when affecting deep organs (lung, liver), but more indolent in skin/soft tissue (though metastasis is possible).
Key Histology: Epithelioid cells arranged in cords/nests in a myxoid/sclerotic background, featuring cytoplasmic vacuoles ("blister cells") that represent abortive lumens.
Molecular Diagnosis: Diagnosed by WWTR1-CAMTA1 translocation, or occasionally Yap-TFE3 translocation.
Pitfall: Often expresses keratin, making it easily confused with metastatic carcinoma or Epithelioid Sarcoma.
33:50 – 36:39 Kaposiform Hemangioendothelioma (KHE): Typically a large mass in infants. The main danger is Kasabach-Merritt syndrome (KMS) — consumptive coagulopathy leading to bleeding/death in ~10% of cases.
Histology: Characteristic "cannonball" nodules of spindled cells with compressed slit-like vascular channels where platelets are sequestered.
Related Entity: Tufted angioma is the adult counterpart; microscopically identical but lacks the association with KMS.
37:18 – 40:48 Epithelioid Sarcoma-Like HE (ESLHE) / Pseudomyogenic HE:
Unique Presentation: Presents as multiple nodules in multiple tissue planes (skin, subcutis, muscle, bone).
Prognosis: Locally aggressive but rarely kills the patient.
Critical Differential Diagnosis: Epithelioid Sarcoma (ES), a much more aggressive tumor (50%+ mortality).
Molecular Distinction: ESLHE is confirmed by retaining nuclear INI1 expression, which is typically lost in ES.
44:54 – 49:22 Spindle Cell Hemangioma (SCH): Formerly known as "Spindle Cell Hemangioendothelioma" (an obsolete term). Now considered benign.
Histology: Biphasic pattern with cavernous spaces and cellular spindled/epithelioid areas.
Unique Clue: Development of numerous small cytoplasmic vacuoles in endothelial cells, creating a "miniaturized adipocyte-like" appearance.
49:24 – 51:13 Microvenular Hemangioma: A benign angioma whose infiltrative growth and slit-like channels can mimic Kaposi Sarcoma (KS). Distinguished by lack of atypia, mitoses, and plasma cell infiltrate.
51:14 – 53:54 Epithelioid Angioma (Angiolymphoid Hyperplasia with Eosinophilia - ALH): Characterized by plump epithelioid endothelial cells ("hobnailing"), often with prominent lymphoid/eosinophil infiltrate. Pitfall: The penile subtype can look aggressive and be misdiagnosed as Angiosarcoma, leading to severe surgical complications.
1:03:36 – 1:05:41 Value of Patient Support Groups: Patients with rare sarcomas often gather detailed information about their disease, including signs, progression, and treatment regimens, providing a valuable resource for doctors and other patients.